Other OTC - Delayed Quote • USD
Atreca, Inc. (BCEL)
At close: April 23 at 3:55 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| BAKER BROS ADVISORS L.P. Unknown | Sale | Oct 19, 2023 | -- |
| CAVET GUY LAWRENCE Chief Technology Officer | Sale | Feb 25, 2020 | 87,758 |
| COURTNEY PHILLIPS General Counsel | Sale | Sep 1, 2023 | 50,431 |
| CROSS HERBERT C Chief Financial Officer | Sale | Aug 2, 2023 | 72,817 |
| GOULD STEPHEN E PH.D. Officer | Sale | Aug 2, 2023 | 28,424 |
| GREENBERG NORMAN MICHAEL Officer | Sale | Mar 17, 2021 | -- |
| ORWIN JOHN A Chief Executive Officer | Sale | Sep 1, 2023 | 77,541 |
| ROBINSON WILLIAM HEWITT Director | Sale | Mar 15, 2021 | 368,948 |
| SERAFINI TITO A Director | Sale | Apr 1, 2024 | 322,511 |
| STEINMAN LAWRENCE Director | Conversion of Exercise of derivative security | Jun 24, 2019 | 258,405 |
Related Tickers
GOSS Gossamer Bio, Inc.
0.7376
-0.73%
ALEC Alector, Inc.
5.34
+3.29%
BDTX Black Diamond Therapeutics, Inc.
5.01
-0.20%
PASG Passage Bio, Inc.
1.2300
+7.89%
AVRO AVROBIO, Inc.
1.2100
+0.83%
BTTX Better Therapeutics, Inc.
0.0060
-1.64%
HOOK HOOKIPA Pharma Inc.
0.7650
+8.20%
STOK Stoke Therapeutics, Inc.
11.25
0.00%
CMRA Comera Life Sciences Holdings, Inc.
0.0410
0.00%
DTIL Precision BioSciences, Inc.
10.23
+5.68%